General Psychiatry
General Psychiatry RSS Feed RSS

Seven Clinical Pearls for Suicide Risk Assessment

June 1, 2012
Timothy W. Lineberry, MD
Timothy W. Lineberry, MD Associate professor of psychiatry, Mayo Clinic Dr. Lineberry has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
Assessing a patient’s risk of suicide is one of the most common, yet challenging, exercises for the psychiatrist.
Read More

Managing the Risk of Prescription Drug Abuse

June 1, 2012
Burns Woodward, MD
Burns Woodward, MD Private practice of psychiatry, Norwood and Newton, Massachusetts Dr. Woodward has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
We’ve all been taught not to prescribe addictive drugs to patients who will abuse them, but in the real world it is not always easy to tell who those patients are or to manage the resulting problems.
Read More

How to Reduce Risk for You and Your Patients

June 1, 2012
Paul S. Appelbaum, MD
Paul S. Appelbaum, MD Professor of psychiatry, Director, Division of Psychiatry, Law and Ethics, Columbia University Dr. Appelbaum has disclosed that he has no relevant relationships or financial interests in any commercial companies related to this educational activity.
What are some ways clinicians can minimize the risks to patients and their own liability in psychiatric practice? Dr. Paul Appelbaum explores risk management in clinical practice in this month’s Q&A.
Read More

Patient Preference Not a Good Predictor of Treatment Response

June 1, 2012
Glen Spielmans, PhD
Glen Spielmans, PhD Associate professor of psychology, Metropolitan State University, St. Paul, MN Glen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Do patients with major depressive disorder (MDD) respond better when psychiatrists offer the type of treatment—medication or psychotherapy—that the patient prefers?
Read More

Text Messaging Effective for Appointment Reminders

June 1, 2012
Glen Spielmans, PhD
Glen Spielmans, PhD Associate professor of psychology, Metropolitan State University, St. Paul, MN Glen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
No one seems to be without a cell phone these days, so it only makes sense that we should start using these devices to carry out tasks that we used to do in a more “old-fashioned” way.
Read More

Is It Possible that Antidepressants Really Don’t Work?

May 1, 2012
Michael Posternak, MD
Michael Posternak, MD Psychiatrist in private practice, Boston, MA Dr. Posternak has disclosed that he has no relevant relationships or financial interests in any commercial company related to this educational activity.
A heated debate over how well psychiatric medications actually work has led some authorities in our field to suggest that psychiatry is currently experiencing a “crisis of confidence.”
Read More

Future Developments in Antidepressant Therapy

May 1, 2012
Kelly Gable, PharmD, BCPP and Steve Balt, MD
Kelly Gable, PharmD, BCPP Assistant professor of pharmacy practice, Southern Illinois University, Edwardsville, School of Pharmacy Dr. Gable has disclosed that she has no relevant relationships or financial interests in any commercial companies pertaining to this educational activity. Steve Balt, MD Research fellow, Addiction Pharmacology Research Laboratory, California Pacific Medical Center Dr. Balt discloses that his spouse is employed as a sales representative for Bristol Myers Squibb.
In 2011 in the pages of TCPR, we asked, “What’s new in antidepressant treatment?” The answer was “not much” (TCPR, April 2011). In 2012, unfortunately, the answer isn’t very different.
Read More
EXPERT Q&A

Predicting Antidepressant Response

May 1, 2012
Andrew Leuchter, MD
Andrew Leuchter, MD

Professor of psychiatry, David Geffen School of Medicine, Director, Laboratory of Brain, Behavior, and Pharmacology, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles
Dr. Leuchter has disclosed that he has been a paid consultant to NeoSync Inc. on the NeoSync EEG Synchronized TMS device (NEST). Dr. Balt has reviewed this article and found no evidence of bias in this educational activity.

I don’t think that there is any effective, proven way to predict medication response. I have been involved in research on biomarkers—we call them “response endophenotypes”—such as EEG, where we look at the physiologic response of the brain to a new drug and try to determine whether the drug will work for that patient.
Read More
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
Featured Video
Featured Podcast
  • shutterstock_2635946985.jpg
    General Psychiatry

    AI in Practice

    Listen now
Recommended

About

Shop Online

Newsletters

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.